Literature DB >> 16298150

Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.

Mohammad Warda1, Robert J Linhardt.   

Abstract

Glycosaminoglycans (GAGs) are the portion of a proteoglycan that determine its final shape and function. The molecular structure of predominant GAG species in camel liver and lung is reported for the first time. The one-humped camel survives in an extreme, arid habitat and, thus, offers a good model to study the role of glycomics on homeostasis. Heparan sulfate (HS) from the lung and liver of the one-humped camel were isolated. Characterization of these newly isolated glycosaminoglycans included (1)H NMR spectroscopy and disaccharide compositional analysis. The relative molecular weight of these GAGs was estimated by gradient polyacrylamide gel electrophoresis and their degree of sulfation was also assessed. Anticoagulant activity was determined using an anti-factor Xa assay and the HS from camel lung shows approximately 50% of heparin's activity. The structural differences of camel liver GAGs compared to human and porcine liver heparin and HS is discussed. Camel lung heparan sulfate resembles both heparin and HS in its structure and properties suggesting that it is either a highly sulfated form of HS, a mixture of heparin and HS or an undersulfated heparin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298150      PMCID: PMC4142637          DOI: 10.1016/j.cbpb.2005.09.015

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  41 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.

Authors:  Y Chen; T Maguire; R E Hileman; J R Fromm; J D Esko; R J Linhardt; R M Marks
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.

Authors:  Omar A Ibrahimi; Brian K Yeh; Anna V Eliseenkova; Fuming Zhang; Shaun K Olsen; Makoto Igarashi; Stuart A Aaronson; Robert J Linhardt; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 4.  Experimental and human liver fibrogenesis.

Authors:  I Kovalszky; P Nagy; B Szende; K Lapis; F Szalay; A Jeney; Z Schaff
Journal:  Scand J Gastroenterol Suppl       Date:  1998

5.  Inhibition of adenylate cyclase of rat hepatic membranes by glycosaminoglycans.

Authors:  J Dittmann; C Keller; G Harisch
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

6.  Structural characterization of human liver heparan sulfate.

Authors:  Preeyanat Vongchan; Mohamad Warda; Hidenao Toyoda; Toshihiko Toida; Rory M Marks; Robert J Linhardt
Journal:  Biochim Biophys Acta       Date:  2004-11-11

7.  Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species.

Authors:  T Toida; H Yoshida; H Toyoda; I Koshiishi; T Imanari; R E Hileman; J R Fromm; R J Linhardt
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

8.  Observations on the fine structure of the liver in the camel (Camelus dromedarius).

Authors:  S Lalla; W Drommer
Journal:  Anat Histol Embryol       Date:  1997-12       Impact factor: 1.114

Review 9.  New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

Authors:  L B Schonberger
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

10.  Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.

Authors:  Marina Cesaretti; Elisa Luppi; Francesca Maccari; Nicola Volpi
Journal:  Glycobiology       Date:  2004-07-14       Impact factor: 4.313

View more
  5 in total

1.  Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate.

Authors:  Arjun Raghuraman; Vaibhav Tiwari; Qian Zhao; Deepak Shukla; Asim K Debnath; Umesh R Desai
Journal:  Biomacromolecules       Date:  2007-04-17       Impact factor: 6.988

2.  Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry.

Authors:  Bo Yang; Yuqing Chang; Amanda M Weyers; Eric Sterner; Robert J Linhardt
Journal:  J Chromatogr A       Date:  2011-12-26       Impact factor: 4.759

3.  Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells.

Authors:  Jay N Thakkar; Vaibhav Tiwari; Umesh R Desai
Journal:  Biomacromolecules       Date:  2010-05-10       Impact factor: 6.988

4.  Glycosaminoglycans from chicken muscular stomach or gizzard.

Authors:  Yin Chen; Megan Reddy; Yanlei Yu; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2016-10-17       Impact factor: 2.916

5.  Isolation and characterization of heparan sulfate from various murine tissues.

Authors:  Mohamad Warda; Toshihiko Toida; Fuming Zhang; Peilong Sun; Eva Munoz; Jin Xie; Robert J Linhardt
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.